← Back to Search
Music-Enhanced Reciprocal Imitation Training for Autism in Toddlers
Nashville, TN
N/A
Recruiting
Led By Warren Jones
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
diagnosis of autism / autism spectrum disorder
18-36 months of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 2-weeks follow-up after intervention
Awards & highlights
No Placebo-Only Group
Summary
This trial examines how well autistic toddlers respond to an evidence-based intervention (RIT) with or without music to help with their imitation and social communication skills. Eye gaze data is collected during the intervention.
See full description
Who is the study for?
This trial is for toddlers aged 18-36 months who have been diagnosed with autism or autism spectrum disorder. It's designed to help improve their imitation and social communication skills.Check my eligibility
What is being tested?
The study tests two types of training: standard Reciprocal Imitation Training (RIT) and a music-enhanced version of RIT, to see which better supports the development of autistic toddlers.See study design
What are the potential side effects?
Since this trial involves behavioral interventions rather than medication, traditional side effects are not expected. However, there may be variations in individual responses to the training.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with autism or ASD.
show original
Select...
I am between 18 and 36 months old.
show original
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline to 2-weeks follow-up after intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 2-weeks follow-up after intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in rhythmically entrained eye-looking (eye-tracking)
Secondary study objectives
Change in child elicited motor imitation
Change in child spontaneous motor imitation
Change in overall fixation to eyes (eye-tracking)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Music-Enhanced Reciprocal Imitation Training (meRIT)Experimental Treatment1 Intervention
Children (n=20) receive 30 sessions of music-enhanced Reciprocal Imitation Training (meRIT), delivered in 40-60 minute sessions 2-3 times/week.
Group II: Reciprocal Imitation Training (RIT)Active Control1 Intervention
Children (n=20) receive 30 sessions of Reciprocal Imitation Training (RIT), delivered in 40-60 minute sessions 2-3 times/week.
Find a Location
Closest Location:Vanderbilt University Medical Center· Nashville, TN
Who is running the clinical trial?
National Institute of Mental Health (NIMH)NIH
3,004 Previous Clinical Trials
2,852,230 Total Patients Enrolled
84 Trials studying Autism Spectrum Disorder
41,083 Patients Enrolled for Autism Spectrum Disorder
National Center for Complementary and Integrative Health (NCCIH)NIH
881 Previous Clinical Trials
676,041 Total Patients Enrolled
3 Trials studying Autism Spectrum Disorder
187 Patients Enrolled for Autism Spectrum Disorder
Vanderbilt University Medical CenterLead Sponsor
919 Previous Clinical Trials
938,719 Total Patients Enrolled
16 Trials studying Autism Spectrum Disorder
2,405 Patients Enrolled for Autism Spectrum Disorder
Warren JonesPrincipal InvestigatorEmory University
Miriam LensePrincipal InvestigatorVanderbilt University Medical Center
Media Library
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.